December 21, 2023
Spotlight on Dr Peya Gaye, Senior Clinical Project Manager, Medicines Development for Global Health
Dr Peya Gaye joined Medicines Development for Global Health in March 2023. Based in Senegal, Peya is managing the ongoing Phase 3b/4 repeat dose study of moxidectin in onchocerciasis. She is an international clinical research specialist with 15 years experience in the conduct of clinical trials in Europe, North America, Africa, and Asia, acting as Clinical Operations Manager, Project Manager, Investigational Product Manager and Senior Clinical Research Associate. Peya has more than 10 years of experience in the management and monitoring of clinical trials from Phase 1 to Phase 4 in different therapeutic areas including ovarian cancer, lung cancer, breast cancer, pain management, malaria, ebola virus disease, and COVID-19.
Peya has worked in both high- and low-income countries and has developed specific technical expertise to implement and manage ICH-GCP clinical trials in challenging environments. Most recently she worked on a 30-country platform trial for the World Health Organization.
Peya has a PhD in Microbiological and Water Chemistry from University of Poitiers and a post-graduate diploma in Epidemiology from University of Bordeaux, both in France.